Medical students, however, are using the drug to reduce the spread of deadly infections such as Ebola and hepatitis C.
A new study by a research team led by researchers at the University of Michigan’s School of Engineering found that a simple injection of the drug into the nose can be enough to eliminate infections in both mice and humans.
The team found that injecting mice with the drug led to the production of a compound that was capable of killing bacteria, viruses and fungi within 10 days.
The team says that this compound is the first ever found to work on the surface of a living cell, in the same way that vaccines work on humans.
“The compound we’re using is a unique one.
It’s not just another antibiotic.
This compound works by blocking the formation of viruses and bacteria that are known to be harmful to humans,” said Dr. David A. Waddington, lead author of the study.”
We’re seeing a very strong case of the ‘magic bullet,’ that we could be getting at a very reasonable price.
We’re looking at $2,000 per dose.
That’s a lot of money, but we think that it’s worth it,” said Waddingham, who also has a doctorate in biomedical engineering.
Waddington says the drug’s ability to block viruses and other pathogens is a crucial step towards treating infections.
“Our studies are demonstrating that there are some very promising potential drug targets for treating some of the infections we see,” he said.
“One of the things that makes this drug so effective is that it blocks many different kinds of viruses.
We are finding that when we give this drug to mice and they have the virus, it actually kills the virus,” Waddham said.
Infections have become increasingly deadly in recent years, as outbreaks have hit the United States and elsewhere around the world.
In 2015, the U.S. Centers for Disease Control and Prevention declared a state of emergency over the deadly coronavirus outbreak, and since then, a number of countries have imposed restrictions on the use of certain antibiotics, which have helped stem the spread.
The study was published in the journal Molecular Infectious Diseases.
Follow CBSMIAMI.COM: Facebook | Twitter | Instagram